Table 2.
Cox regression analysis of the non-HDL-C/HDL-C ratio and 1-year risk of recurrent stroke in patients with NICE
Variable | Overall | Event, n% | Crude model HR(95%CI) |
P value | Adjusted model HR(95%CI) |
P value |
---|---|---|---|---|---|---|
Non-HDL-C/HDL-C ratio, per 1 unit increase | 1659 | 58(3.5) | 1.09(0.89 ~ 1.33) | 0.425 | 1.43(1.11 ~ 1.84) | 0.005 |
Non-HDL-C/HDL-C ratio quartile | ||||||
Q1 | 415 | 11(2.7) | Ref. | Ref. | ||
Q2 | 414 | 15(3.6) | 1.37(0.63 ~ 2.97) | 0.432 | 1.79(0.75 ~ 4.27) | 0.189 |
Q3 | 415 | 16(3.9) | 1.45(0.68 ~ 3.13) | 0.339 | 2.27(0.96 ~ 5.38) | 0.063 |
Q4 | 415 | 16(3.9) | 1.45(0.67 ~ 3.12) | 0.344 | 2.70(1.06 ~ 6.89) | 0.037 |
P for trend | 0.355 | 0.03 |
Notes: Crude adjust none; adjusted for age, sex; smoking, drinking, prior stroke, pneumonia, NIHSS score at admission, BMI, ALT, triglyceride, FBG, alkaline phosphatase, platelet count, blood urea nitrogen, hypertension, atrial fibrillation, and diabetes mellitus. Abbreviations: BMI, body mass index; FBG, fasting blood glucose; NIHSS, national institutes of health stroke scale; ALT, alanine aminotransferase; HR, hazard ratio; CI, confidence interval; and Q, quartile. Q1: <2.256, Q2:2.256–2.939, Q3: 2.940–3.749, Q4: ≥3.750